Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JENNIFER S GRAVES

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1992849863
CMS profile
271388
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$106,649.15

  • Reported across 218 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$23,845.89

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $21,192.30 5
TG THERAPEUTICS, INC. $821.31 3
Alexion Pharmaceuticals, Inc. $673.56 2
NOVARTIS PHARMACEUTICALS CORPORATION $398.68 12
EMD Serono, Inc. $284.44 2
Amgen Inc. $278.29 6
Roche Products Limited $126.25 1
Biogen, Inc. $47.81 2
Genentech USA, Inc. $23.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $14,878.73 18
PY2019 $32,132.89 57
PY2020 $15,328.08 26
PY2021 $7,703.37 15
PY2022 $4,920.22 20
PY2023 $7,839.97 48
PY2024 $23,845.89 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $670.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1093995554 CMS
Alexion Pharmaceuticals, Inc. $3.56 10/02/2024 Food and Beverage Undisputed 01/23/2026 1094038918 CMS
Amgen Inc. $33.27 02/22/2024 Food and Beverage Undisputed 01/23/2026 1111588560 CMS
Amgen Inc. $32.44 03/21/2024 Food and Beverage Undisputed 01/23/2026 1111588562 CMS
Amgen Inc. $31.65 06/28/2024 Food and Beverage Undisputed 01/23/2026 1111588564 CMS
Amgen Inc. $70.52 07/19/2024 Food and Beverage Undisputed 01/23/2026 1111588566 CMS
Amgen Inc. $33.97 07/25/2024 Food and Beverage Undisputed 01/23/2026 1111588568 CMS
Amgen Inc. $76.44 07/26/2024 Food and Beverage Undisputed 01/23/2026 1111588570 CMS
Biogen, Inc. $19.32 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104875980 CMS
Biogen, Inc. $28.49 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104835469 CMS
EMD Serono, Inc. $147.79 04/22/2024 Food and Beverage Undisputed 01/23/2026 1120247715 CMS
EMD Serono, Inc. $136.65 05/30/2024 Food and Beverage Undisputed 01/23/2026 1120248673 CMS
Genentech USA, Inc. $23.25 09/25/2024 Food and Beverage Undisputed 01/23/2026 1133030768 CMS
GENZYME CORPORATION $2,157.00 05/12/2024 Consulting Fee Undisputed 01/23/2026 1139859196 CMS
GENZYME CORPORATION $265.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1139859198 CMS
GENZYME CORPORATION $457.04 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1139859200 CMS
GENZYME CORPORATION $190.26 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1139859202 CMS
GENZYME CORPORATION $18,123.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1139859204 CMS
Novartis Pharmaceuticals Corporation $71.40 01/30/2024 Food and Beverage Undisputed 01/23/2026 1086784845 CMS
Novartis Pharmaceuticals Corporation $21.75 04/10/2024 Food and Beverage Undisputed 01/23/2026 1086784855 CMS
Novartis Pharmaceuticals Corporation $2.69 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086784859 CMS
Novartis Pharmaceuticals Corporation $18.59 05/22/2024 Food and Beverage Undisputed 01/23/2026 1086784873 CMS
Novartis Pharmaceuticals Corporation $130.29 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086784869 CMS
Novartis Pharmaceuticals Corporation $17.20 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086784875 CMS
Novartis Pharmaceuticals Corporation $78.22 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086784877 CMS
Novartis Pharmaceuticals Corporation $4.72 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086784881 CMS
Novartis Pharmaceuticals Corporation $25.51 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086784883 CMS
Novartis Pharmaceuticals Corporation $2.34 08/22/2024 Food and Beverage Undisputed 01/23/2026 1086784885 CMS
Novartis Pharmaceuticals Corporation $7.55 08/22/2024 Food and Beverage Undisputed 01/23/2026 1086784887 CMS
Novartis Pharmaceuticals Corporation $18.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 1086784895 CMS
Roche Products Limited $126.25 04/14/2024 Food and Beverage Undisputed 01/23/2026 1133030772 CMS
TG Therapeutics, Inc. $118.58 06/13/2024 Food and Beverage Undisputed 01/23/2026 1136874865 CMS
TG Therapeutics, Inc. $675.00 06/27/2024 Consulting Fee Undisputed 01/23/2026 1136874775 CMS
TG Therapeutics, Inc. $27.73 12/18/2024 Food and Beverage Undisputed 01/23/2026 1136874877 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.